Skip to main content

Table 1 Sociodemographic and clinical characteristics of study participants

From: Potential drug–drug interactions in patients with cardiovascular diseases: findings from a prospective observational study

Variables No. (%)/Mean ± SD/median (range)
Gender  
 Female 132 (44.0)
 Male 168 (56.0)
Age (years)  
 18–30 18 (6.0)
 31–40 39 (13.0)
 41–50 54 (18.0)
 51–60 72 (24.0)
 > 60 117 (39.0)
Hospital  
 BMCH 150 (50.0)
 SPH 150 (50.0)
Residence  
 Rural 141 (47.0)
 Urban 159 (53.0)
Nationality  
 Pakistani 267 (89.0)
 Afghan 33 (11.0)
Smoking  
 Non-smokers 177 (59.0)
 Ex-smokers 24 (8.0)
 Active smokers 99 (33.0)
Type of CVD  
 STEMI 123 (41.0)
 NSTEMI 33 (11.0)
 CAD 21 (7.0)
 Cardiomyopathy 69 (23.0)
 Valvular heart disease 12 (4.0)
 Heart failure 24 (8.0)
 Cardiac arrhythmias 18(6.0)
Comorbidity  
 No 120 (40.0)
 Yes 180 (60.0)
Number of comorbidities 1 (0–3)
 0 120 (40.0)
 1 96 (32.0)
 2 66 (22.0)
 3 18 (6.0)
Types of comorbidity  
 Hypertension 116
 Diabetes mellitus 78
 Anemia 22
 Others 45
Length of hospital stay (days) 4.45 ± 2.40 (2–14)
 ≤ 3 (49.0)
 4–7 (42.0)
 > 7 (9.0)
Number of drugs prescribed 10.21 ± 2.6 (6–21)
 6–9 135 (45.0)
 10–12 114 (38.0)
 > 12 57 (17.0)
  1. CAD coronary artery disease; CVD cardiovascular disease; NSTEMI non-ST elevated myocardial infarction; SD standard deviation; STEMI ST-elevated myocardial infarction